Astrazeneca (AZN) Stock Price

$67.3 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    6

  • Fundamental

    8

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Astrazeneca, AI stock picks, stock alerts and much more.

Sign up

AZN AI Stock Analysis

AI stock analysis for AZN is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Astrazeneca (AZN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Astrazeneca (AZN) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Astrazeneca (AZN), currently trading at $67.3, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About AZN

LSE

  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines.

  • Symbol

    AZN

  • Market

    NASDAQ

  • Industry

    Drug Manufacturers - General

  • Market Cap

    417.3B

Similar Stocks

AMGN Amgen
AMGN		 $272.1
1.4%
4
GILD Gilead Sciences
GILD		 $98.16
0.8%
6
SNY Sanofi
SNY		 $52.13
0.3%
5
BIIB Biogen
BIIB		 $118.4
1%
4

News

AstraZeneca's Imfinzi delays bladder cancer return in high-risk patients

AstraZeneca's Imfinzi delays bladder cancer return in high-risk patients
May 9, 2025. proactiveinvestors.co.uk
Tempus AI Stock: Time to Double Down or Cut and Run?

Tempus AI Stock: Time to Double Down or Cut and Run?
May 8, 2025. marketbeat.com
AstraZeneca and GSK slide as Trump and RFK appoint new FDA vaccine chief

AstraZeneca and GSK slide as Trump and RFK appoint new FDA vaccine chief
May 7, 2025. proactiveinvestors.co.uk
AstraZeneca's Breztri meets main goals of late-stage asthma trials

AstraZeneca's Breztri meets main goals of late-stage asthma trials
May 2, 2025. reuters.com

AZN Alternative Data

Web Traffic

Astrazeneca receives an estimated 769352 monthly visitors to astrazeneca.com.

  • Web Traffic

    769352

  • Change from Previous Month

    6.5%

  • 3 Month Change

    6.2%

  • YoY Change

    6.2%

Twitter Followers

Astrazeneca has 296,491 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.

  • Twitter Followers

    296491

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0.6%

  • YoY Change

    0.6%

Facebook Engagement

Astrazeneca has engaged 70 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    70

  • Daily Change

    15.7%

  • 1 Month Change

    52.1%

  • 3 Month Change

    57.3%

  • YoY Change

    57.3%

Instagram Followers

Astrazeneca has 82,895 Instagram Followers on its main Instagram account, up by 1.3% over the last month.

  • Instagram Followers

    82895

  • Daily Change

    0.1%

  • 1 Month Change

    1.3%

  • 3 Month Change

    4.1%

  • YoY Change

    4.1%

Youtube Subscribers

Astrazeneca has 18,100 subscribers on its main Youtube channel, up by 1.1% over the last month.

  • Youtube Subscribers

    18100

  • Daily Change

    0.6%

  • 1 Month Change

    1.1%

  • 3 Month Change

    2.8%

  • YoY Change

    2.8%

LinkedIn Followers

3,230,091 are following Astrazeneca on LinkedIn, up by 1.3% over the last month.

  • LinkedIn Followers

    3230091

  • Daily Change

    0%

  • 1 Month Change

    1.3%

  • 3 Month Change

    3.6%

Job Postings

Astrazeneca currenly has an estimated 1,000 open job postings.

  • Job Postings

    1000

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, Astrazeneca has 77,029 employees, up by 0.7% over the last month.

  • LinkedIn Employees

    77029

  • Daily Change

    0.1%

  • 1 Month Change

    0.7%

  • 3 Month Change

    1.5%

  • YoY Change

    1.5%

Reddit Mentions

Astrazeneca has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

News Mentions

Astrazeneca was mentioned 12 times in the news yesterday.

  • News Mentions

    12

  • Daily Change

    14.3%

  • 1 Month Change

    33.3%

  • 3 Month Change

    20%

Business Outlook

According to employee reviews, the business outlook among employees at Astrazeneca is 82 out of 100 (very bullish).

  • Business Outlook

    82

  • Change from Previous Month

    1.2%

  • 3 Month Change

    0%

  • YoY Change

    0%

AZN Financials

AZN Key Metrics

  • Total Revenue

    $13.6B

  • Net Income

    $2.9B

  • Earnings per Share

    $0.47

  • Free cash flow

    $2.7B

  • EBITDA

    $5B

  • EBITDA Ratio

    0.371063

  • Total Assets

    $106.3B

AZN 2-year Revenue & Income
AZN 2-year Free Cash Flow

AZN Technicals

AZN SMA
AZN RSI

FAQ

What's the current price of Astrazeneca (AZN) Stock?
The price of an Astrazeneca (AZN) share is $67.3.

What's the market cap of Astrazeneca?
The current market cap of Astrazeneca is 417.3B.

Should I buy or sell AZN?
Astrazeneca shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Astrazeneca is better viewed as a hold or accumulate position while waiting for further developments.

Is Astrazeneca a good investment?
The current analysis of Astrazeneca's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Astrazeneca's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Astrazeneca (AZN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Astrazeneca stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Astrazeneca (AZN) that investors often compare it to?
Astrazeneca (AZN) is often compared to similar stocks such as Amgen, Gilead Sciences, Sanofi and Biogen.

What is the forecast for Astrazeneca's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Astrazeneca's stock price to be around $70.46 in 2026. Starting from the current price of $67.3, this represents a 4.7% change in price, indicating a neutral outlook for the stock.

How to buy Astrazeneca (AZN) Stock?
Astrazeneca stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Astrazeneca shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.